secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001558370-24-004786
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma issues $2M senior secured convertible note at 25%, convertible at $2.50
--------------------------------------------------------------------------------

- Issued $2,000,000 25% Senior Secured Convertible Promissory Note to an accredited investor.
- Note matures April 2, 2025; interest rate 25% (27% upon default).
- Initial conversion price $2.50 per share, with 19.99% beneficial ownership limitation.
- Note secured by all fixtures, equipment, and intellectual property of the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000155837024004786/0001558370-24-004786-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000155837024004786/krbp-20240402x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-004786

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer